First Manhattan’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-160
Closed -$11K 1624
2022
Q1
$11K Hold
160
﹤0.01% 1261
2021
Q4
$15K Hold
160
﹤0.01% 1214
2021
Q3
$13K Hold
160
﹤0.01% 1230
2021
Q2
$13K Hold
160
﹤0.01% 1230
2021
Q1
$15K Buy
+160
New +$15K ﹤0.01% 1173
2013
Q4
Sell
-2,348
Closed -$63K 1396
2013
Q3
$63K Hold
2,348
﹤0.01% 879
2013
Q2
$69K Buy
+2,348
New +$69K ﹤0.01% 866